510(k) Report

510(k) · Cleared

Cleared

Vitros Chemistry Products Benz Reagent, Calibrator Kit 26, FS Calibrator 1 and Dat Performance Verifiers I, II, Iii, IV

K062285510(k) TraditionalCleared Dec 22, 2006137-day reviewClass II21 CFR 862.3170

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ortho-Clinical Diagnostics, Inc. · JXM Enzyme Immunoassay, Benzodiazepine

Cleared on Dec 22, 2006 as substantially equivalent to K993985 (Syva Co., 2000) and 1 other predicate after a 137-day review. Its family tree reaches back 1 generation to 2000.

Decided
Dec 22, 2006
Review
137 days
Class
Class II
Product code
JXM
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K993985 (2000). 2 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2002: 1 other ancestorK993985 · Syva Emit II Plus Benzodiazepine Assay, Models 9F029UL/9F129UL · Syva Co. · 200020002002200420062008
Other ancestors, by generation 1 generation back: 1 other ancestor K993985 · Syva Emit II Plus Benzodiazepine Assay, Models 9F029UL/9F129UL · Syva Co. · 20000
  1. Root · 1 generation backK993985 Syva Emit II Plus Benzodiazepine Assay, Models 9F029UL/9F129ULSyva Co. · 2000
  2. This deviceK062285 Vitros Chemistry Products Benz Reagent, Calibrator Kit 26, FS…Ortho-Clinical Diagnostics, Inc. · 2006
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K993985Syva Emit II Plus Benzodiazepine Assay, Models 9F029UL/9F129ULSyva Co.2000—
0 (this device)K062285Vitros Chemistry Products Benz Reagent, Calibrator Kit 26, FS Calibrator 1 and…Ortho-Clinical Diagnostics, Inc.2006—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200210
FIG. 1 — Lineage of K062285, 2000–2006Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JXM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JXM device

  1. #1 K243498 Alinity c Benzodiazepines Reagent Kitscore 8.8 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K993985Syva Emit II Plus Benzodiazepine Assay, Models 9F029UL/9F129UL
Summary page 4
…erformance Verifiers are substantially equivalent to the devices DADE BEHRING Syva® EMIT® II Plus Benzodiazepine Assay (K993985) and BIO-RAD LiquichekT M Urine Toxicology Controls (K022707) (predicate devices) which were cleared…
Syva Co.2000—
*K022707Liquichek Urine Toxicology Control Level S1E, Model 438; Level S2E, Model 439
Summary page 4
…BEHRING Syva® EMIT® II Plus Benzodiazepine Assay (K993985) and BIO-RAD LiquichekT M Urine Toxicology Controls (K022707) (predicate devices) which were cleared by the FDA for in vitro diagnostic use.…
Bio-Rad2002—

Also cleared against K993985: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 2 ancestors has a recall.
  • 1 other device also cites its predicate K993985.

How does its category compare?

All JXM devices

JXM Enzyme Immunoassay, Benzodiazepine: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JXM

1in 2024

2010: 12011: 12012: 12015: 22016: 22017: 22018: 12019: 12022: 12024: 1
2007high 2 (2015) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JXM

Too few JXM 510(k)s in any year since 2007 to give a median.

Recalls per year · JXM

79in 2015

2015: 79
2007high 79 (2015) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JXM

6in 2025

2008: 32009: 12010: 32011: 32012: 12013: 32014: 32015: 52016: 22017: 42018: 42019: 32021: 12023: 52024: 62025: 6
2007high 6 (2024) · low 0 (2007)2025

MAUDE reports naming product code JXM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—03
20090—01
20101—03
20111—03
20121—01
20130—03
20140—03
20152—795
20162—02
20172—04
20181—04
20191—03
20200—00
20210—01
20221—00
20230—05
20241—06
20250—06
20260—0—

What is it indicated for?

VITROS Chemistry Products BENZ Reagent is used on VITROS 5,1 FS Chemistry Systems for the semi-quantitative or qualitative determination of benzodiazepines (BENZ) in human urine using a cutoff of either 200 ng/mL or 300 ng/mL. Measurements obtained with the VITROS BENZ method are used in the diagnosis and treatment of benzodiazepines use or overdose. The VITROS Chemistry Products BENZ assay is intended for use by professional laboratory personnel. It…

Read the full statement (213 words)

VITROS Chemistry Products BENZ Reagent is used on VITROS 5,1 FS Chemistry Systems for the semi-quantitative or qualitative determination of benzodiazepines (BENZ) in human urine using a cutoff of either 200 ng/mL or 300 ng/mL. Measurements obtained with the VITROS BENZ method are used in the diagnosis and treatment of benzodiazepines use or overdose.

The VITROS Chemistry Products BENZ assay is intended for use by professional laboratory personnel. It provides only a preliminary test result. A more specific alternative chemical method must be used to confirm a result obtained with this assay. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug-of-abuse test result, particularly when evaluating a preliminary positive result.

For in vitro diagnostic use only. VITROS Chemistry Products Calibrator Kit 26 is used to calibrate VITROS 5,1 FS Chemistry Systems for the qualitative or semi-quantitative measurement of drugs of abuse.

For in vitro diagnostic use only. VITROS Chemistry Products FS Calibrator 1 is used in conjunction with VITROS Chemistry Products Calibrator Kits to calibrate VITROS 5,1 FS Chemistry Systems.

For in vitro diagnostic use only. VITROS Chemistry Products DAT Performance Verifiers are assayed controls used to monitor performance of urine drugs of abuse screening assays on VITROS 5,1 FS Chemistry Systems.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K062285: Vitros Chemistry Products Benz Reagent, Calibrator Kit 26, FS Calibrator 1 and Dat Performance Verifiers I, II, Iii, IV.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K062285

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026